What is the difference between Lenalidomide and Pomalidomide? How to choose?

Lenalidomide and pomalidomide are both immunomodulatory drugs used to treat malignant blood diseases such as multiple myeloma. Although they share some similarities in their mechanisms of action and therapeutic effects, there are also some important differences, and which drug to choose depends on the patient's specific situation and the recommendations of his or her doctor. The differences between these two drugs and how to choose are discussed in detail below.

1. Mechanism of action:

Lenalidomide: Lenalidomide is an immunomodulatory drug whose main effects include inhibiting the growth and proliferation of tumor cells, enhancing the activity of the immune system, and reducing angiogenesis. It controls the progression of multiple myeloma through a variety of mechanisms and is often used in conjunction with other drugs such as dexamethasone.

Pomalidomide: Pomalidomide is also an immunomodulatory drug whose mechanism of action is similar to that of lenalidomide, including inhibiting the growth and proliferation of tumor cells. However, pomalidomide is generally considered a more potent drug for some patients with multiple myeloma, especially those who have developed resistance to lenalidomide and other treatments.

2. Indications:

Lenalidomide: Lenalidomide is widely used in the first-line treatment of multiple myeloma and in the treatment of relapsed multiple myeloma/Refractory multiple myeloma. It is often used in combination with dexamethasone or other medications to control the progression of the disease.

Pomalidomide Pomalidomide is generally reserved for patients with multiple myeloma who have already received lenalidomide and other treatments and still have relapse or drug resistance. It is often used to treat refractory multiple myeloma.

3. Side effects:

Lenalidomide: Common side effects of lenalidomide include anemia, neutropenia, thrombocytopenia, skin rash, nausea, fatigue, etc. In addition, it has certain toxicity and may have harmful effects on the fetus, so female patients need to take contraceptive measures during treatment.

Pomalidomide: The side effects of pomalidomide are similar to those of lenalidomide but may be more severe in some ways. Common side effects include anemia, neutropenia, increased risk of infection, nausea, fatigue, etc. Due to its potent nature, pomalidomide may be more toxic and patients require close monitoring and management.

4. Select:

The choice between lenalidomide and pomalidomide should be based on the patient's condition and treatment history, as well as the recommendations of the physician. Generally speaking:

For first-line treatment of multiple myeloma, lenalidomide combined with other drugs, such as dexamethasone, is usually the first choice. Pomalidomide is typically reserved for the setting of relapsed or refractory multiple myeloma.

Pomalidomide may be a more potent alternative for patients who develop resistance to lenalidomide or experience relapse after taking lenalidomide.

The final decision should be made by the physician based on the patient's specific situation and the latest treatment guidelines.

Lenalidomide has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price is around 3,500~4,000 yuan. Due to different medical insurance policies in various places, the price also varies. Please consult your local pharmacy for specific prices. There are also original research drugs in China, but the price is as high as tens of thousands of yuan, so it is not recommended to buy them. The cheaper ones abroad are mainly generic drugs, including those from India, Bangladesh, and Laos, which cost about a few hundred yuan per box. The ingredients of foreign generic drugs and domestic lenalidomide drugs are basically the same.

Pomalidomide has been launched in China and has been included in medical insurance. Patients can purchase it domestically. Different specifications have different prices. The price is about 3000~7000 yuan. Due to different medical insurance policies in different places, the price is also different. Please consult the local pharmacy for details. Foreign pomalidomide is divided into original drugs and generic drugs. The original drugs are mainly Turkish generic drugs, the specification is 4mg*21 and the price is about 17,000 yuan; the generic drugs are mainly Indian generic drugs and Laos generic drugs, and the price ranges from 300 to 400 to more than 1,000 yuan. The ingredients of original drugs and generic drugs are basically the same as domestic drugs.